Photo detail

Stories this photo appears in:

Cardium Enters Strategic Collaboration, Will Change Name

Cardium Therapeutics Inc. has entered a strategic collaboration and funding arrangement with Shanxi Taxus Pharmaceuticals Co. Ltd. of China to support the worldwide clinical and commercial development of San Diego-based Cardium’s regenerative medicine therapeutics products.

Tease photo

Cardium Therapeutics Voluntarily Delists From NYSE, Will Rejoin OTC Market

Cardium Therapeutics Inc. announced that it elected to delist from the New York Stock Exchange and voluntarily begin trading on the OTC exchange.

Tease photo

Cardium Therapeutics Provides Update on Exchange Listing Compliance

Cardium Therapeutics Inc., which could face possible suspension or removal from the New York Stock Exchange, has until Jan. 6, 2014 to submit an updated plan of compliance to the exchange.

Tease photo